CID 24950192

5-(piperidin-4-yl)-2,3-dihydro-1,3,4-oxadiazol-2-one hydrochloride

Structural Information

Molecular Formula
C7H11N3O2
SMILES
C1CNCCC1C2=NNC(=O)O2
InChI
InChI=1S/C7H11N3O2/c11-7-10-9-6(12-7)5-1-3-8-4-2-5/h5,8H,1-4H2,(H,10,11)
InChIKey
QMIAMKPZGHFEJM-UHFFFAOYSA-N
Compound name
5-piperidin-4-yl-3H-1,3,4-oxadiazol-2-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

34
Patents

169.08513 Da
Monoisotopic Mass

-0.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 170.092406 135.0
[M+Na]+ 192.074348 141.8
[M-H]- 168.077854 135.2
[M+NH4]+ 187.118953 149.9
[M+K]+ 208.048288 139.6
[M+H-H2O]+ 152.082390 126.8
[M+HCOO]- 214.083331 150.7
[M+CH3COO]- 228.098981 146.3
[M+Na-2H]- 190.059796 139.8
[M]+ 169.08458142 129.0
[M]- 169.08567858 129.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe